Vazegepant

CAS No. 1337918-83-8

Vazegepant( —— )

Catalog No. M35066 CAS No. 1337918-83-8

Vazegepant (Zavegepant) is an orally available and selective antagonist of the calcitonin gene-related peptide CGRP receptor for pain relief and may be used in the study of migraine.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 161 Get Quote
5MG 227 Get Quote
10MG 337 Get Quote
25MG 593 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Vazegepant
  • Note
    Research use only, not for human use.
  • Brief Description
    Vazegepant (Zavegepant) is an orally available and selective antagonist of the calcitonin gene-related peptide CGRP receptor for pain relief and may be used in the study of migraine.
  • Description
    Vazegepant (Zavegepant) is an orally active calcitonin gene-related peptideCGRP receptor antagonist with potential for acute research in migraine. CGRP is an important trigger in migraine pathophysiology.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    CGRP Receptor
  • Recptor
    CGRP Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1337918-83-8
  • Formula Weight
    638.8
  • Molecular Formula
    C36H46N8O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1C(=CC=2C(N1)=CC=CC2)C3CCN(C(N[C@H](CC=4C=C5C(=C(C)C4)NN=C5)C(=O)N6CCN(CC6)C7CCN(C)CC7)=O)CC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Leonard KA, et al. Discovery of a Gut-Restricted JAK Inhibitor for the Treatment of Inflammatory Bowel Disease. J Med Chem. 2020 Mar 26;63(6):2915-2929.?
molnova catalog
related products
  • PHM 27 (human)

    Endogenous peptide product of human prepro-VIP and analog of porcine PHI-27; potent agonist for the human calcitonin receptor (EC50 = 11 nM). Transgenic mice expressing the human VIP/PHM 27 gene in pancreatic β-islets display enhanced glucose-induced insulin secretion.

  • MK-8825

    MK-8825 is a highly potent, selective, orally bioavailable CGRP receptor antagonist with Ki of 17 nM for rat CGRP.

  • MK-3207 (Hydrochlori...

    A highly potent, selective CGRP receptor antagonist with Ki of 21 pM in in vitro binding assay and IC50 of 0.12 nM in cell-based functional assay.